| Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma L Gong, DLW Kwong, W Dai, P Wu, S Li, Q Yan, Y Zhang, B Zhang, ... Nature communications 12 (1), 1540, 2021 | 115 | 2021 |
| Cancer cell reprogramming: a promising therapy converting malignancy to benignity L Gong, Q Yan, Y Zhang, X Fang, B Liu, X Guan Cancer communications 39, 1-13, 2019 | 69 | 2019 |
| C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism Y Zhang, Q Yan, L Gong, H Xu, B Liu, X Fang, D Yu, L Li, T Wei, Y Wang, ... Oncogene 40 (6), 1147-1161, 2021 | 59 | 2021 |
| Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo T Wu, Z Chen, KKW To, X Fang, F Wang, B Cheng, L Fu Biochemical pharmacology 124, 29-42, 2017 | 52 | 2017 |
| Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo Z Zhang, X Guo, KKW To, Z Chen, X Fang, M Luo, C Ma, J Xu, S Yan, L Fu Acta pharmaceutica sinica B 8 (4), 563-574, 2018 | 29 | 2018 |
| Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy SB Liang, JJ Teng, XF Hu, XL Yang, M Luo, XN Fang, DS Liu, Y Chen, ... BMC cancer 17, 1-10, 2017 | 25 | 2017 |
| PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors Q Yan, Y Zhang, X Fang, B Liu, TL Wong, L Gong, S Liu, D Yu, M Liu, ... Cell Death & Differentiation 28 (6), 1955-1970, 2021 | 22 | 2021 |
| MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC M Xu, F Wang, G Li, X Wang, X Fang, H Jin, Z Chen, J Zhang, L Fu Molecular cancer 18, 1-14, 2019 | 22 | 2019 |
| Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction L Gong, J Luo, Y Zhang, Y Yang, S Li, X Fang, B Zhang, J Huang, ... Nature Communications 14 (1), 1912, 2023 | 20 | 2023 |
| Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma B Liu, X Fang, DLW Kwong, Y Zhang, K Verhoeft, L Gong, B Zhang, ... Journal of Experimental & Clinical Cancer Research 41 (1), 182, 2022 | 18 | 2022 |
| Cancer stem cells in hepatocellular carcinoma: intrinsic and extrinsic molecular mechanisms in stemness regulation X Fang, Q Yan, S Liu, XY Guan International journal of molecular sciences 23 (20), 12327, 2022 | 16 | 2022 |
| Oncofetal proteins and cancer stem cells Q Yan, X Fang, C Li, P Lan, X Guan Essays in Biochemistry 66 (4), 423-433, 2022 | 13 | 2022 |
| Ceritinib enhances the efficacy of substrate chemotherapeutic agent in human ABCB1-overexpressing leukemia cells in vitro, in vivo and ex-vivo L Yang, M Li, F Wang, C Zhen, M Luo, X Fang, H Zhang, J Zhang, Q Li, ... Cellular Physiology and Biochemistry 46 (6), 2487-2499, 2018 | 12 | 2018 |
| Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC J Luo, L Gong, Y Yang, Y Zhang, Q Liu, L Bai, X Fang, B Zhang, J Huang, ... Hepatology 79 (1), 61-78, 2024 | 9 | 2024 |
| MAEL augments cancer stemness properties and resistance to sorafenib in hepatocellular carcinoma through the PTGS2/AKT/STAT3 axis C Shi, DLW Kwong, X Li, X Wang, X Fang, L Sun, Y Tang, XY Guan, SS Li Cancers 14 (12), 2880, 2022 | 9 | 2022 |
| Predictive efficacy biomarkers of programmed cell death 1/programmed cell death 1 ligand blockade therapy XN Fang, LW Fu Recent Patents on Anti-Cancer Drug Discovery 11 (2), 141-151, 2016 | 9 | 2016 |
| PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis X Fang, H Xie, M Luo, Z Chen, F Wang, Q Li, X Wang, J Ding, L Fu Biochemical Pharmacology 150, 131-140, 2018 | 7 | 2018 |
| Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment L Gong, Y Zhang, Y Yang, Q Yan, J Ren, J Luo, YC Tiu, X Fang, B Liu, ... Hepatology Communications 6 (11), 3194-3211, 2022 | 5 | 2022 |
| LOXL1 promotes tumor cell malignancy and restricts CD8+ T cell infiltration in colorectal cancer C Li, S Chen, X Fang, Y Du, XY Guan, R Lin, L Xu, P Lan, Q Yan Cell Biology and Toxicology 40 (1), 6, 2024 | 2 | 2024 |
| Loss of ESRP2 Activates TAK1‐MAPK Signaling through the Fetal RNA‐Splicing Program to Promote Hepatocellular Carcinoma Progression Q Yan, X Fang, X Liu, S Guo, S Chen, M Luo, P Lan, XY Guan Advanced Science 11 (1), 2305653, 2024 | 2 | 2024 |
